Rgs2 Mediates Pro-Angiogenic Function of Myeloid Derived Suppressor Cells in the Tumor Microenvironment via Upregulation of MCP-1

Open Access

Peer-reviewed

Research Article

Kimberly C. Boelte,

Affiliation Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
⨯
Laura E. Gordy,

Affiliation Department of Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
⨯
Sebastian Joyce,

Affiliation Department of Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
⨯
Mary Ann Thompson,

Affiliation Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
⨯
Li Yang,

Affiliation Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, United States of America
⨯
P. Charles Lin

* E-mail: p.lin@nih.gov

Affiliation Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, United States of America
⨯

Reader Comments (0)

Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Endothelial cells
Is the Subject Area "Endothelial cells" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Spleen
Is the Subject Area "Spleen" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.